WallStreetZenWallStreetZen

NASDAQ: GNPX
Genprex Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Genprex earnings were -$16.9M for the trailing 12 months ending Sep 30, 2026, with -91.7% growth year over year. The latest GNPX earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$4.2M, down 4.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GNPX reported annual earnings of -$16.2M, with -24.1% growth.

GNPX past earnings growth

How has GNPX's earnings growth performed historically?

Company
-91.7%
Industry
74.54%
Market
93.55%
GNPX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GNPX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

GNPX earnings history

Current Revenue
$0.0
Current Earnings
-$16.9M
Current Profit Margin
0%

GNPX Return on Equity

Current Company
-126.8%
Current Industry
-19%
Current Market
36.9%
GNPX's Return on Equity (-126.8%)... subscribe to Premium to read more.
High Return on Equity Performance

GNPX Return on Assets

Current Company
-104%
Current Industry
-8.5%
GNPX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GNPX announces earnings.

GNPX Return on Capital Employed

Current Company
-123.4%
Current Industry
-4.4%
GNPX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GNPX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GNPX-$16.94M-$16.94M-91.70%$94.20
NRSN-$9.86M-$9.98MN/A-$7.10
ERNA-$13.86M-$13.97MN/A-$12.24
REVB-$11.95M-$17.84M-92.83%$73.98
VIVS-$9.61M-$10.27MN/A-$3.52
View Top Biotech Stocks

Genprex Earnings Reports & History FAQ

What were Genprex's earnings last quarter?

On GNPX's earnings call on Nov 13, 2026, Genprex (NASDAQ: GNPX) reported Q3 2026 earnings per share (EPS) of -$5.30, up 95.15% year over year. Total GNPX earnings for the quarter were -$4.24 million. In the same quarter last year, Genprex's earnings per share (EPS) was -$109.39.

If you're new to stock investing, here's how to buy Genprex stock.

Is Genprex profitable or losing money?

As of the last Genprex earnings report, Genprex is currently losing money. Genprex's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$16.94 million, a 0.99% increase year over year.

What was GNPX's earnings growth in the past year?

As of Genprex's earnings date in Nov 13, 2026, Genprex's earnings has grown -91.7% year over year. This is 166.25 percentage points lower than the US Biotechnology industry earnings growth rate of 74.54%. GNPX earnings in the past year totalled -$16.94 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.